Skip to main content
915 TLDR
Health
1 read

Pfizer's Lyme Disease Vaccine Shows 70% Effectiveness Pending Approval

KTSMAshleigh Fields
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

Pfizer has announced that its Lyme disease vaccine demonstrates a 70% effectiveness rate in preventing the illness, pending regulatory approval. If authorized, this vaccine would be the first of its kind for humans, addressing a significant health concern as Lyme disease cases continue to rise. The development is crucial for public health, especially in regions where Lyme disease is prevalent. Residents should stay informed about the vaccine's approval process and potential availability.

health vaccine lyme-disease pfizer

People & Organizations

Pfizer

Related Articles